Stoke Therapeutics (STOK) Research & Development (2018 - 2026)
Stoke Therapeutics (STOK) reported Research & Development of $49.5 million for Q2 2026, up 91.5% from $25.86 million a year earlier and up 24.8% from the prior quarter.
Powered by 
Analysis
Stoke Therapeutics (STOK) Research & Development (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Stoke Therapeutics' Research & Development came in at $168.57 million, up 61.8% year-over-year; for FY2025, it came in at $137.92 million, up 54.7% from FY2024.
- Research & Development has increased for seven consecutive years, with a five-year compound annual growth rate of 33.8% (FY2020 to FY2025).
- By year, Research & Development came in at $89.13 million in FY2024 (+8.4%), $82.23 million in FY2023 (+5.6%), $77.84 million in FY2022 (+43.7%) and $54.17 million in FY2021 (+68.2%).
- The Q2 2026 figure ranks as the highest quarterly Research & Development in data going back to Q2 2018.
- Year over year, Research & Development has now increased in each of the last 29 quarters, with growth averaging 43.3% over the last eight quarters.
- The year-over-year growth in Research & Development has ranged between 0.8% (Q3 2023) and 91.5% (Q2 2026) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at $39.67 million (Q1 2026), $41.7 million (Q4 2025) and $37.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,135.43 Bn | 1,104.02 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 616.54 Bn | 535.06 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 501.55 Bn | 474.66 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 367.19 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.91 Bn | 261.90 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.40 Bn | 235.09 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.18 Bn | 191.58 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 190.55 Bn | 164.75 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 169.40 Bn | 116.05 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Stoke Therapeutics | 1.69 Bn | 519.39 Mn | - | 49.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.50 Mn |
| Mar 31, 2026 | 39.67 Mn |
| Dec 31, 2025 | 41.70 Mn |
| Sep 30, 2025 | 37.70 Mn |
| Jun 30, 2025 | 25.86 Mn |
| Mar 31, 2025 | 32.68 Mn |
| Dec 31, 2024 | 23.42 Mn |
| Sep 30, 2024 | 22.21 Mn |
| Jun 30, 2024 | 21.14 Mn |
| Mar 31, 2024 | 22.37 Mn |
| Dec 31, 2023 | 21.78 Mn |
| Sep 30, 2023 | 20.27 Mn |
| Jun 30, 2023 | 20.55 Mn |
| Mar 31, 2023 | 19.63 Mn |
| Dec 31, 2022 | 21.06 Mn |
| Sep 30, 2022 | 20.11 Mn |
| Jun 30, 2022 | 18.36 Mn |
| Mar 31, 2022 | 18.31 Mn |
| Dec 31, 2021 | 15.80 Mn |
| Sep 30, 2021 | 14.36 Mn |
API Access
Stoke Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=STOK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "STOK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=STOK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();